Dedicated to the industry that saved my son

Olivier Kerckhove, Director at Real Life Sciences, France and Benelux explains how a 1 in 66,000 experience changed his outlook and makes him proud to be part of the life sciences industry.

At the heart

I’ve been with Real Life Sciences for 14 years, and over the years I’ve seen the amazing impact the people we represent have had on the life sciences industry and the treatments available.

But it was only when my own son, Jules who was three weeks old at the time, became seriously ill that I saw first hand how advances in the life sciences industry can change the outlook for a family.

It all started when Jules had a severe cold, as he was so small we took him to the hospital where he stayed for weeks under observation. Eventually, doctors worked out his trachea was more than 90% compressed. They operated immediately and we spent three months at the hospital while he recovered.

One in 66,000

The odds were so small, it’s hard to believe that Jules was that one person to have this, doctors said they’d never dealt with this sort of case before. It was the unknown, and seeing Jules suffer, that was the hardest. We had complete faith in the team and the treatments he was receiving and now doctors have assured us he will make a full recovery by the time he is one to two years old.

Thinking back about our journey, it was the heart surgeon and his team who saved little Jules’ life, and they were able to do their jobs to such a high standard thanks to the tools they use – many of which have been developed by companies we know well at Real Life Sciences.

I know that one day Jules will ask me what I do for a living. When he does, I’m going to tell him that I change people’s lives, by helping wonderful people find a new job to contribute to the development of new medicines and tools that are used by doctors and surgeons around the world. It might only be a small part of the life sciences industry, but I am honoured to be a part of it.

Read Olivier's full story. 

Real Life Sciences will attend DIA 2019

01 Nov 2019

Real Life Sciences will be partnering with DIA (Drug Information Association) Japan’s Annual Meeting this year again. We have established a strong partnership with DIA around the world, including Europe, the United States, and Singapore, and we are pleased to be a part of a leading community of professionals within the life science industry.

Tags: DIA PHARMA

Can Korea’s medical affairs teams overcome barriers to success?

01 May 2019

Find out if Korea’s medical affairs teams are able to overcome barriers to success?

Real Life Sciences Singapore expands to Hong Kong

01 Apr 2019

Read more about Real Life Sciences in Hong Kong

How will global trends shake up South Korea’s medical scene?

01 Mar 2019

Read about how global trends shake up South Korea’s medical scene?